• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Foundation Medicine

edit

Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.

Recent Milestones

edit

• 
  Foundation Medicine received $13.5M in Series B funding. (1/8/13)
  Posted 1/27/13 at 10:12pm via foundationmedicine.com
• 
  Foundation Medicine received $42.5M in Series B funding. (9/20/12)
  Posted 9/20/12 at 6:14pm via finsmes.com
• 
  Foundation Medicine received $33.5M in Series A funding. (10/18/11)
  Posted 4/19/10 at 7:53am via finsmes.com
• 
  Foundation Medicine — has named Gary Palmer as senior vice president, medical affairs and commercial development (1/19/11)
  Posted 1/20/11 at 3:56am via masshightech.com
• 
  Foundation Medicine — has inked a collaboration deal with Swiss drug giant Novartis AG to tailor Foundation’s genome-based tests to Novartis’ needs (1/4/11)
  Posted 1/5/11 at 6:35am via masshightech.com
• 
  Foundation Medicine — has appointed Maureen Cronin in the newly created role of senior vice president of research and product development (11/12/10)
  Posted 11/16/10 at 4:29am via masshightech.com
• 
  Foundation Medicine added Michael J. Pellini as President and CEO.
  Posted 5/12/11 at 6:56pm

Videos

Screenshots

edit

Sources

1. Foundation Medicine Closes $33.5M Expanded Series A Financing (finsmes.com) [edit]
2. Foundation Medicine Closes $42.5M Series B Funding (finsmes.com) [edit]
3. Foundation Medicine Expands Series B Financing to $56 Million (foundationmedicine.com) [edit]
Foundation Medicine names Cronin as new SVP (masshightech.com) [edit]
Foundation Medicine, Novartis team up on cancer diagnostics (masshightech.com) [edit]
Foundation Medicine appoints Palmer to new VP role (masshightech.com) [edit]